genomics

COVID-19 a year later: What have we learned?

We’ve learned a lot during the past year about how to address global crises, but in my mind, one lesson cannot be ignored: The need for more strategic collaborations across institutions and sectors.

Continue reading

IBM Research and the Broad Institute Seek to Unravel the True Risks of Genetic Diseases

In 2019, IBM and the Broad Institute of MIT and Harvard started a multi-year collaborative research program to develop powerful predictive models that can potentially enable clinicians to identify patients at serious risk for cardiovascular disease (1, 2). At the start of our collaboration, we proposed an approach to develop AI-based models that combine and […]

Continue reading

What’s in your food? A new technology platform shows early signs of promise

Food authentication is emerging as an important field, and at IBM Research we are applying a multidisciplinary approach in collaboration with industry and academia to address this global challenge.

Continue reading

Leading Food Safety’s Technology-Driven Future

When the first bacterial genome was sequenced in 1995, it was impossible to imagine the new ways that humans would put microbes to work in service of food safety and security. But today, big data can be paired with microbial sequencing to monitor the microbial ecosystem of food and detect potential threats, transforming the field […]

Continue reading

Cracking the Cancer Code with Watson Genomics

Since the time of Egyptians building pyramids, we’ve known about the impact cancer has on humankind. It is the second leading cause of death in the US1, based on data from 2010 through 2012, nearly 40 percent of Americans will develop it in their lifetime; one in four men and one in five women are […]

Continue reading